Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Nov;16(11):1720-1722.
doi: 10.2215/CJN.06450521. Epub 2021 Jul 26.

Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients

Jeffrey G Mulhern  1 , Amit Fadia  2 , Ruchir Patel  3 , Linda H Ficociello  4 , Joanna Willetts  4 , Ines A Dahne-Steuber  5 , Melanie C Pollan  6 , Claudy Mullon  4   7 , Josephine DeLisi  5 , Curtis Johnson  8 , Chance Mysayphonh  4 , Robert J Kossmann  4 , Michael S Anger  4   7 , Jeffrey L Hymes  4
Affiliations
Observational Study

Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients

Jeffrey G Mulhern et al. Clin J Am Soc Nephrol. 2021 Nov.
No abstract available

Keywords: COVID-19; SARS-CoV-2; antibody; dialysis; vaccination.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Antibody levels by history of coronavirus disease 2019 (COVID-19) before vaccination and type of vaccination. First and last postvaccination antibody levels by group are presented in the figure with red or blue indicating patients with or without history of COVID-19. Horizontal dotted lines are drawn at antibody index 1 and 7 to indicate detected and adequate antibody response and 750 to indicate the maximum detected level. Median antibody index among patients without history of COVID-19 was 85 (interquartile range [IQR], 15–152) and 0.5 (IQR, 0.5–1.6) at first measurement and 24 (IQR, 6–91) and 0.7 (IQR, 0.5–2.0) at last measurement for patients vaccinated with mRNA and Ad26.COV2.S, respectively. Measurements <0.5 and >750 index were included in the calculation as 0.5 and 750, respectively. Median (IQR) antibody index among patients with history of COVID-19 was 750 (IQR, 750–750) and 177 (IQR, 93–272) at first measurement and 750 (IQR, 750–750) and 159 (IQR, 5–530) at last measurement for patients vaccinated with mRNA and Ad26.COV2.S, respectively.
See this image and copyright information in PMC

References

    1. Siemens Healthcare Diagnostics : ADVIA Centaur XP/XPT S ARS-CoV-2 IgG (COV2G) Instructions for use. Available at: https://www.fda.gov/media/140704/download. Accessed April 18, 2021
    1. US Food and Drug Administration : Investigational COVID-19 convalescent plasma: Guidance for industry. May 1, 2020. Available at: https://www.hhs.gov/guidance/document/investigational-covid-19-convalesc.... Accessed May 3, 2021
    1. Conklin J, Freeman J, Patel S, Vero L, Pennamon G, Glatz J: Evaluation of the enhanced SARS-CoV-2 IgG (sCOVG) assay* on the Atellica IM Analyzer. Poster presented at: The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Virtual Conference on Critical Role of Clinical Laboratories in the Covid-19 Pandemic; February 15–17, 2021
    1. Stephenson KE, Le Gars M, Sadoff J, de Groot AM, Heerwegh D, Truyers C, Atyeo C, Loos C, Chandrashekar A, McMahan K, Tostanoski LH, Yu J, Gebre MS, Jacob-Dolan C, Li Z, Patel S, Peter L, Liu J, Borducchi EN, Nkolola JP, Souza M, Tan CS, Zash R, Julg B, Nathavitharana RR, Shapiro RL, Azim AA, Alonso CD, Jaegle K, Ansel JL, Kanjilal DG, Guiney CJ, Bradshaw C, Tyler A, Makoni T, Yanosick KE, Seaman MS, Lauffenburger DA, Alter G, Struyf F, Douoguih M, Van Hoof J, Schuitemaker H, Barouch DH: Immunogenicity of the Ad26.COV2.S vaccine for COVID-19. JAMA 325: 1535–1544, 2021 - PMC - PubMed

MeSH terms